{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:55:26Z","timestamp":1773766526132,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.det.2011.11.008","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T14:58:39Z","timestamp":1324393119000},"page":"301-307","source":"Crossref","is-referenced-by-count":29,"title":["Quality-of-Life Measurement in Blistering Diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"Deshan F.","family":"Sebaratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereydoun","family":"Davatchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2011.11.008_bib1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization","volume":"41","author":"WHOQOL Group","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.det.2011.11.008_bib2","unstructured":"World Health Organization. Constitution of the world health organization. In: Basic documents, 45th edition, Supplement, October 2006 from the Fifty-First World Health Assembly. Geneva (Switzerland): WHO; 2006. p. 1."},{"key":"10.1016\/j.det.2011.11.008_bib3","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1038\/sj.jid.5701176","article-title":"Dermatology quality of life instruments: sorting out the quagmire","volume":"127","author":"Chen","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.det.2011.11.008_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refine version of Skindex, a quality-of-life instrument for patients with skin diseases","volume":"133","author":"Chren","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib6","first-page":"27726","article-title":"Critical review of generic and dermatology-specific health-related quality of life instruments","volume":"127","author":"Both","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.det.2009.10.019","article-title":"Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care","volume":"28","author":"Frew","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2011.11.008_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clindermatol.2011.03.016","article-title":"Quality of life in patients with bullous dermatoses","volume":"30","author":"Sebaratnam","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB","volume":"58","author":"Fine","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2230.2002.01121.x","article-title":"Quality of life in epidermolysis bullosa","volume":"27","author":"Horn","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2230.2004.01428.x","article-title":"Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa","volume":"29","author":"Fine","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1365-2133.2004.06339.x","article-title":"Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size","volume":"152","author":"Fine","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","article-title":"Quality of life in patients with epidermolysis bullosa","volume":"161","author":"Tabolli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib15","series-title":"A\u00a0user\u2019s guide to the General Health Questionnaire","author":"Goldberg","year":"1988"},{"key":"10.1016\/j.det.2011.11.008_bib16","series-title":"The measurement and validation of health status using EQ-5D: a European perspective","author":"Brooks","year":"2005"},{"key":"10.1016\/j.det.2011.11.008_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1023\/B:QURE.0000040795.78742.72","article-title":"Update on family strain questionnaire: a tool for the general screening of caregiving-related problems","volume":"13","author":"Ferrario","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.det.2011.11.008_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10880-010-9205-4","article-title":"Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa","volume":"17","author":"Margari","year":"2010","journal-title":"J\u00a0Clin Psychol Med Settings"},{"key":"10.1016\/j.det.2011.11.008_bib19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2133.2009.09347.x","article-title":"Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument","volume":"161","author":"Frew","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2340\/00015555-0376","article-title":"Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews","volume":"88","author":"van Scheppingen","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2011.11.008_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1049732311400431","article-title":"The psychosocial impact of epidermolysis bullosa","volume":"21","author":"Dures","year":"2011","journal-title":"Qual Health Res"},{"key":"10.1016\/j.det.2011.11.008_bib22","first-page":"S67","volume":"130","author":"Venugopal","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.det.2011.11.008_bib23","first-page":"26","article-title":"Quality of life outcomes of cultured allogeneic fibroblast therapy recipients with epidermolysis bullosa","volume":"52","author":"Frew","year":"2011","journal-title":"Aust J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib24","first-page":"283","article-title":"An investigation of quality of life (QOL) of pemphigus patients in Japan (first report)","volume":"110","author":"Masahiro","year":"2000","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0151-9638(05)79276-0","article-title":"Quality of life and pemphigus","volume":"132","author":"Terrab","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2011.11.008_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1610-0387.2005.05722.x","volume":"3","author":"Mayrshofer","year":"2005","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.11.008_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2133.2008.08481.x","article-title":"The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire","volume":"158","author":"Tabolli","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib28","series-title":"Handbook for the IPAT depression scale","author":"Krug","year":"1976"},{"key":"10.1016\/j.det.2011.11.008_bib29","series-title":"Handbook for the IPAT anxiety scale","author":"Krug","year":"1976"},{"key":"10.1016\/j.det.2011.11.008_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2005.07071.x","article-title":"Measuring quality of life of patients with different clinical types of psoriasis using the SF-36","volume":"154","author":"Sampogna","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaad.2008.09.014","article-title":"Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools","volume":"60","author":"Paradisi","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.det.2011.11.008_bib32","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s00403-002-0367-2","article-title":"History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan","volume":"295","author":"Ikeda","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2011.11.008_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2133.2005.06909.x","article-title":"Age, gender, quality of life and psychological distress in patients hospitalised with psoriasis","volume":"154","author":"Sampogna","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib34","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disease Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib35","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Reliability and convergent validity of two outcome instruments in pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.11.008_bib36","first-page":"1","article-title":"Comparison of the health-related quality of life of patients suffering from pemphigus with healthy people","volume":"17","author":"Darjani","year":"2008","journal-title":"Journal of Guilan University of Medical Sciences"},{"key":"10.1016\/j.det.2011.11.008_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00642887","article-title":"The Swedish Health-Related Quality of Life Survey","volume":"2","author":"Brorsson","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.det.2011.11.008_bib38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1590\/S0037-86822010000500022","volume":"43","author":"Tim\u00f3teo","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"issue":"Suppl 1","key":"10.1016\/j.det.2011.11.008_bib39","first-page":"27","article-title":"A\u00a0disease-specific quality of life instrument for autoimmune bullous diseases\u2014the ABQOL","volume":"52","author":"Hanna","year":"2010","journal-title":"Aust J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.det.2011.11.008_bib40","first-page":"S33","article-title":"The development of a disease-specific quality of life instrument for autoimmune bullous dermatoses: the ABQOL","volume":"131","author":"Hanna","year":"2011","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863511002038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863511002038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T03:32:55Z","timestamp":1561087975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863511002038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0733863511002038"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2011.11.008","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}